Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$WVE Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.30 up 6.25% YoY • Reported revenue of $13.16M up 72.93% YoY • Wave Life Sciences expects current cash, cash equivalents, and marketable securities to fund operations into 3Q 2028; a $12M GSK milestone is expected in 4Q 2026 and is excluded from runway.
1

Price since post

Full Details

Advertisement|Remove ads.